Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 255 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2926 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2021-05-20 | 2021-07-22 | 139749 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-06-16 | 2022-09-08 | 162861 |
| TEVA-RISPERIDONE | 3.0MG | TABLET | Resolved | 2022-09-07 | 2022-12-22 | 168744 |
| TEVA-RISPERIDONE | 1.0MG | TABLET | Resolved | 2022-09-22 | 2022-12-22 | 170004 |
| TEVA-RISPERIDONE | 4MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176782 |
| TEVA-RIVAROXABAN | 15MG | TABLET | Resolved | 2024-02-15 | 2024-07-03 | 219671 |
| TEVA-RIVAROXABAN | 20MG | TABLET | Resolved | 2024-05-09 | 2024-06-17 | 227456 |
| TEVA-RIVAROXABAN | 20MG | TABLET | Resolved | 2024-06-27 | 2025-01-09 | 231436 |
| TEVA-RIVAROXABAN | 10MG | TABLET | Resolved | 2025-03-06 | 2025-03-07 | 252087 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-05-10 | 2017-09-19 | 9805 |
| TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-08-22 | 2019-09-19 | 92151 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-08-22 | 2019-11-21 | 92154 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-09-24 | 2020-10-30 | 124992 |
| TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-02-18 | 2021-04-15 | 134340 |
| TEVA-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2022-09-22 | 2023-04-28 | 169983 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-02-09 | 2023-04-28 | 184213 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2023-10-05 | 2023-11-09 | 206428 |
| TEVA-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Actual shortage | 2025-06-19 | 2025-12-11 | 260630 |
| TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-07-23 | 2020-08-17 | 120875 |
| TEVA-ROPINIROLE | 2MG | TABLET | Resolved | 2020-07-30 | 2020-08-17 | 121500 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |